Preclinical Models of Fragile X Syndrome and CDKL5 Deficiency Disorder: Learning from Patients

Time: 10:50 am
day: Day One


  • How can we get more from preclinical models by listening to patients and their families?
  • Translational composite biomarkers are key: fluid biomarkers, neurophysiology, and naturalistic behaviours
  • How do we rethink the mouse models for FXS and CDD? How can we improve our ways of doing translational research?